Table of Contents
2019-2024 Global Antihypertensive Drugs Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Antihypertensive Drugs Consumption 2014-2024
2.1.2 Antihypertensive Drugs Consumption CAGR by Region
2.2 Antihypertensive Drugs Segment by Type
2.2.1 Diuretic Antihypertensive
2.2.2 Sympathetic Suppressant
2.2.3 Renin-angiotensin System Inhibitor
2.2.4 Calcium Antagonist Medicine
2.2.5 vasodilator
2.3 Antihypertensive Drugs Consumption by Type
2.3.1 Global Antihypertensive Drugs Consumption Market Share by Type (2014-2019)
2.3.2 Global Antihypertensive Drugs Revenue and Market Share by Type (2014-2019)
2.3.3 Global Antihypertensive Drugs Sale Price by Type (2014-2019)
2.4 Antihypertensive Drugs Segment by Application
2.4.1 The Old
2.4.2 Pregnant Woman
2.4.3 General Patient
2.5 Antihypertensive Drugs Consumption by Application
2.5.1 Global Antihypertensive Drugs Consumption Market Share by Application (2014-2019)
2.5.2 Global Antihypertensive Drugs Value and Market Share by Application (2014-2019)
2.5.3 Global Antihypertensive Drugs Sale Price by Application (2014-2019)
3 Global Antihypertensive Drugs by Players
3.1 Global Antihypertensive Drugs Sales Market Share by Players
3.1.1 Global Antihypertensive Drugs Sales by Players (2017-2019)
3.1.2 Global Antihypertensive Drugs Sales Market Share by Players (2017-2019)
3.2 Global Antihypertensive Drugs Revenue Market Share by Players
3.2.1 Global Antihypertensive Drugs Revenue by Players (2017-2019)
3.2.2 Global Antihypertensive Drugs Revenue Market Share by Players (2017-2019)
3.3 Global Antihypertensive Drugs Sale Price by Players
3.4 Global Antihypertensive Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Antihypertensive Drugs Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Antihypertensive Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Antihypertensive Drugs by Regions
4.1 Antihypertensive Drugs by Regions
4.1.1 Global Antihypertensive Drugs Consumption by Regions
4.1.2 Global Antihypertensive Drugs Value by Regions
4.2 Americas Antihypertensive Drugs Consumption Growth
4.3 APAC Antihypertensive Drugs Consumption Growth
4.4 Europe Antihypertensive Drugs Consumption Growth
4.5 Middle East & Africa Antihypertensive Drugs Consumption Growth
5 Americas
5.1 Americas Antihypertensive Drugs Consumption by Countries
5.1.1 Americas Antihypertensive Drugs Consumption by Countries (2014-2019)
5.1.2 Americas Antihypertensive Drugs Value by Countries (2014-2019)
5.2 Americas Antihypertensive Drugs Consumption by Type
5.3 Americas Antihypertensive Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Antihypertensive Drugs Consumption by Countries
6.1.1 APAC Antihypertensive Drugs Consumption by Countries (2014-2019)
6.1.2 APAC Antihypertensive Drugs Value by Countries (2014-2019)
6.2 APAC Antihypertensive Drugs Consumption by Type
6.3 APAC Antihypertensive Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Antihypertensive Drugs by Countries
7.1.1 Europe Antihypertensive Drugs Consumption by Countries (2014-2019)
7.1.2 Europe Antihypertensive Drugs Value by Countries (2014-2019)
7.2 Europe Antihypertensive Drugs Consumption by Type
7.3 Europe Antihypertensive Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Antihypertensive Drugs by Countries
8.1.1 Middle East & Africa Antihypertensive Drugs Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Antihypertensive Drugs Value by Countries (2014-2019)
8.2 Middle East & Africa Antihypertensive Drugs Consumption by Type
8.3 Middle East & Africa Antihypertensive Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Antihypertensive Drugs Distributors
10.3 Antihypertensive Drugs Customer
11 Global Antihypertensive Drugs Market Forecast
11.1 Global Antihypertensive Drugs Consumption Forecast (2019-2024)
11.2 Global Antihypertensive Drugs Forecast by Regions
11.2.1 Global Antihypertensive Drugs Forecast by Regions (2019-2024)
11.2.2 Global Antihypertensive Drugs Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Antihypertensive Drugs Forecast by Type
11.8 Global Antihypertensive Drugs Forecast by Application
12 Key Players Analysis
12.1 Novartis
12.1.1 Company Details
12.1.2 Antihypertensive Drugs Product Offered
12.1.3 Novartis Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Novartis News
12.2 Pfizer
12.2.1 Company Details
12.2.2 Antihypertensive Drugs Product Offered
12.2.3 Pfizer Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Pfizer News
12.3 Johnson & Johnson
12.3.1 Company Details
12.3.2 Antihypertensive Drugs Product Offered
12.3.3 Johnson & Johnson Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Johnson & Johnson News
12.4 Sanofi
12.4.1 Company Details
12.4.2 Antihypertensive Drugs Product Offered
12.4.3 Sanofi Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Sanofi News
12.5 Lupin
12.5.1 Company Details
12.5.2 Antihypertensive Drugs Product Offered
12.5.3 Lupin Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Lupin News
12.6 Ranbaxy Laboratories
12.6.1 Company Details
12.6.2 Antihypertensive Drugs Product Offered
12.6.3 Ranbaxy Laboratories Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Ranbaxy Laboratories News
12.7 Merck
12.7.1 Company Details
12.7.2 Antihypertensive Drugs Product Offered
12.7.3 Merck Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 Merck News
12.8 Astra Zeneca
12.8.1 Company Details
12.8.2 Antihypertensive Drugs Product Offered
12.8.3 Astra Zeneca Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 Astra Zeneca News
12.9 Daiichi Sankyo
12.9.1 Company Details
12.9.2 Antihypertensive Drugs Product Offered
12.9.3 Daiichi Sankyo Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 Daiichi Sankyo News
12.10 Takeda
12.10.1 Company Details
12.10.2 Antihypertensive Drugs Product Offered
12.10.3 Takeda Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Takeda News
12.11 Actelion
12.12 United Therapeutics
13 Research Findings and Conclusion
